Dr Nagham Ailabouni is a clinician-researcher and NHMRC Emerging Leadership Fellow (EL1) at the University of Queensland, Faculty of Health and Behavioural Sciences.
They identify as a person from a culturally and linguistically diverse background (CALD) and is of Palestinian Jordanian descent. Dr Ailabouni's main research interests include implementation science, co-design and consumer engagement in person-centred deprescribing, quality use of medicines in older people, people living with dementia and their carers.
They completed their undergraduate Pharmacy degree at the University of Otago and is an Australian registered pharmacist with clinical pharmacy experience in various healthcare settings including hospital, aged care and community pharmacy. Thereafter, Dr Ailabouni conferred their PhD titled "Deprescribing in Older New Zealanders" from the University of Otago, Dunedin in 2018. Their PhD program was the first to explore deprescribing in New Zealand.
Dr Ailabouni is the Public Engagement Subcommittee Chair of the leading deprescribing network in Australia, the Australian Deprescribing Network and the co-chair of the American Geriatrics Society Polypharmacy and Deprescribing Special Interest Group. They are the Early Career Representative of the School of Pharmacy representing early career researchers within their institution since 2022.
Professionally, Dr Ailabouni was competitively selected as an observer for the Australian Aged Care Quality and Safety Commission, Medication Safety Oversight Committee, since 2023. They were elected and served as the President of the Pharmaceutical Society of New Zealand (PSNZ) Otago Branch in 2014-2016. They were elected once again and served as the President of the PSNZ South Canterbury Branch in 2016-2018.
Dr Ailabouni enjoys being part of early career researchers' professional development and growth. They are currently supervising and mentoring 6 PhD candidates in Australia and New Zealand and looks forward to growing their supervision roles.
Journal Article: The Drug Burden Index and Level of Frailty as Determinants of Healthcare Costs in a Cohort of Older Frail Adults in New Zealand
Duncan, Shnece, Bergler, Hans Ulrich, Menclova, Andrea, Pickering, John W., Nishtala, Prasad S., Ailabouni, Nagham, Hilmer, Sarah N., Mangin, Dee and Jamieson, Hamish (2024). The Drug Burden Index and Level of Frailty as Determinants of Healthcare Costs in a Cohort of Older Frail Adults in New Zealand. Value in Health Regional Issues, 41, 72-79. doi: 10.1016/j.vhri.2023.11.009
Journal Article: Comparative risk of gout flares when initiating or escalating various urate‐lowering therapy: a systematic review with network meta‐analysis
Maher, Dorsa, Reeve, Emily, Hopkins, Ashley, Tan, Jiun Ming, Tantiongco, Mahsa, Ailabouni, Nagham, Woodman, Richard, Stamp, Lisa, Bursill, David, Proudman, Susanna and Wiese, Michael (2024). Comparative risk of gout flares when initiating or escalating various urate‐lowering therapy: a systematic review with network meta‐analysis. Arthritis Care & Research. doi: 10.1002/acr.25309
Page, Amy Theresa, Potter, Kathleen, Lee, Georgie, Almutairi, Hend, Lee, Kenneth, Wang, Kate, Ailabouni, Nagham and Etherton-Beer, Christopher (2024). Medicines Regimens Charted for Older People Living in Residential Aged Care: A Repeated Cross-Sectional Study Describing the Number of Medicines, Regimen Complexity, High-Risk Prescribing, and Potential Underprescribing. Journal of the American Medical Directors Association. doi: 10.1016/j.jamda.2024.01.013
(2024–2028) NHMRC Investigator Grants
(2023–2027) NHMRC MRFF - Preventive and Public Health Research
Co-designing an evidence-based deprescribing training package for clinicians to optimise medication use and reduce risk of medication-related harm for people living with dementia
Doctor Philosophy
Leveraging implementation science concepts to improve the translation of healthcare services that improve Quality Use of Medicines
Doctor Philosophy
Pharmacoepidemiology Research Delivering Evidence About Drug Safety in Older Adults
Ailabouni, Nagham J., Kassie, Gizat M. and Kalisch Ellett, Lisa M. (2022). Pharmacoepidemiology Research Delivering Evidence About Drug Safety in Older Adults. Encyclopedia of Evidence in Pharmaceutical Public Health and Health Services Research in Pharmacy. (pp. 1-11) Cham: Springer International Publishing. doi: 10.1007/978-3-030-50247-8_25-1
Duncan, Shnece, Bergler, Hans Ulrich, Menclova, Andrea, Pickering, John W., Nishtala, Prasad S., Ailabouni, Nagham, Hilmer, Sarah N., Mangin, Dee and Jamieson, Hamish (2024). The Drug Burden Index and Level of Frailty as Determinants of Healthcare Costs in a Cohort of Older Frail Adults in New Zealand. Value in Health Regional Issues, 41, 72-79. doi: 10.1016/j.vhri.2023.11.009
Maher, Dorsa, Reeve, Emily, Hopkins, Ashley, Tan, Jiun Ming, Tantiongco, Mahsa, Ailabouni, Nagham, Woodman, Richard, Stamp, Lisa, Bursill, David, Proudman, Susanna and Wiese, Michael (2024). Comparative risk of gout flares when initiating or escalating various urate‐lowering therapy: a systematic review with network meta‐analysis. Arthritis Care & Research. doi: 10.1002/acr.25309
Page, Amy Theresa, Potter, Kathleen, Lee, Georgie, Almutairi, Hend, Lee, Kenneth, Wang, Kate, Ailabouni, Nagham and Etherton-Beer, Christopher (2024). Medicines Regimens Charted for Older People Living in Residential Aged Care: A Repeated Cross-Sectional Study Describing the Number of Medicines, Regimen Complexity, High-Risk Prescribing, and Potential Underprescribing. Journal of the American Medical Directors Association. doi: 10.1016/j.jamda.2024.01.013
Ailabouni, Nagham J., Weir, Kristie Rebecca, Brandt, Nicole, Hanjani, Leila Shafiee, Green, Ariel, Thompson, Wade, Freeman, Christopher R., Mangin, Dee, Bohill, Ruth, Furst, Chloe and Reeve, Emily (2024). Partnering with a stakeholder steering group to co‐design the PRIME deprescribing conversation tool: reflections and recommendations. Basic and Clinical Pharmacology and Toxicology, 134 (1), 121-125. doi: 10.1111/bcpt.13938
Top 10 unanswered questions about quality use of medicines in people living with dementia
Tan, Edwin, Reeve, Emily, Ailabouni, Nagham, Chenoweth, Lynn, Sawan, Mouna, Nguyen, Tuan Anh, Ellett, Lisa Kalisch, Gilmartin-Thomas, Julia, Sluggett, Janet, Quirke, Lyntara and Hilmer, Sarah (2023). Top 10 unanswered questions about quality use of medicines in people living with dementia. Research in Social and Administrative Pharmacy, 19 (7), 12. doi: 10.1016/j.sapharm.2023.04.035
Reeve, Emily, Chenoweth, Lynn, Sawan, Mouna, Nguyen, Tuan Anh, Kalisch Ellett, Lisa, Gilmartin-Thomas, Julia, Tan, Edwin, Sluggett, Janet K., Quirke, Lyntara S., Tran, Kham, Ailabouni, Nagham, Cowan, Katherine, Sinclair, Ron, de la Perrelle, Lenore, Deimel, Judy, To, Josephine, Daly, Stephanie, Whitehead, Craig and Hilmer, Sarah N. (2023). Consumer and healthcare professional led priority setting for quality use of medicines in people with dementia: gathering unanswered research questions. Journal of Alzheimer's Disease, 91 (3), 933-960. doi: 10.3233/jad-220827
Jamieson, Hamish, Nishtala, Prasad S., Bergler, Hans Ulrich, Weaver, Susan K., Pickering, John W., Ailabouni, Nagham J., Abey-Nesbit, Rebecca, Gullery, Carolyn, Deely, Joanne, Gee, Susan B., Hilmer, Sarah N. and Mangin, Dee (2023). Deprescribing anticholinergic and sedative drugs to reduce polypharmacy in frail older adults living in the community: a randomized controlled trial. The Journals of Gerontology: Series A, 78 (9), 1692-1700. doi: 10.1093/gerona/glac249
Consumer attitudes towards deprescribing: a systematic review and meta-analysis
Weir, Kristie Rebecca, Ailabouni, Nagham J., Schneider, Carl R., Hilmer, Sarah N. and Reeve, Emily (2022). Consumer attitudes towards deprescribing: a systematic review and meta-analysis. The Journals of Gerontology: Series A, 77 (5), 1020-1034. doi: 10.1093/gerona/glab222
Ailabouni, Nagham J., Reeve, Emily, Helfrich, Christian D., Hilmer, Sarah N. and Wagenaar, Bradley H. (2022). Leveraging implementation science to increase the translation of deprescribing evidence into practice. Research in Social and Administrative Pharmacy, 18 (3), 2550-2555. doi: 10.1016/j.sapharm.2021.05.018
Weir, Kristie Rebecca, Ailabouni, Nagham J., Schneider, Carl R., Hilmer, Sarah N. and Reeve, Emily (2022). Considerations for systematic reviews of quantitative surveys: learnings from a systematic review of the Patients’ Attitudes Towards Deprescribing questionnaire. Research in Social and Administrative Pharmacy, 18 (2), 2345-2349. doi: 10.1016/j.sapharm.2021.07.024
Bergler, Ulrich, Ailabouni, Nagham J., Pickering, John W., Hilmer, Sarah N., Mangin, Dee, Nishtala, Prasad S. and Jamieson, Hamish (2021). Deprescribing to reduce polypharmacy: study protocol for a randomised controlled trial assessing deprescribing of anticholinergic and sedative drugs in a cohort of frail older people living in the community. Trials, 22 (1) 766. doi: 10.1186/s13063-021-05711-w
Barriers and enablers of older adults initiating a deprescribing conversation
Ailabouni, Nagham J., Rebecca Weir, Kristie, Reeve, Emily, Turner, Justin T., Wilson Norton, Jennifer and Gray, Shelly L. (2021). Barriers and enablers of older adults initiating a deprescribing conversation. Patient Education and Counseling, 105 (3), 615-624. doi: 10.1016/j.pec.2021.06.021
Ailabouni, Nagham J., Hilmer, Sarah N., Kalisch, Lisa, Braund, Rhiannon and Reeve, Emily (2021). COVID-19 pandemic: considerations for safe medication use in older adults with multimorbidity and polypharmacy. Journals of Gerontology - Series A Biological Sciences and Medical Sciences, 76 (6), 1068-1073. doi: 10.1093/gerona/glaa104
Barthold, Douglas, Marcum, Zachary A., Chen, Shuxian, White, Lindsay, Ailabouni, Nagham, Basu, Anirban, Coe, Norma B. and Gray, Shelly L. (2021). Difficulty with taking medications is associated with future diagnosis of Alzheimer’s disease and related dementias. Journal of General Internal Medicine, 36 (4), 863-868. doi: 10.1007/s11606-020-06279-y
Medication use quality and safety in older adults: 2019 update
Ailabouni, Nagham J., Marcum, Zachary A., Schmader, Kenneth E. and Gray, Shelly L. (2021). Medication use quality and safety in older adults: 2019 update. Journal of the American Geriatrics Society, 69 (2), 336-341. doi: 10.1111/jgs.17018
Alterations in drug disposition in older adults: a focus on geriatric syndromes
Maher, Dorsa, Ailabouni, Nagham, Mangoni, Arduino A., Wiese, Michael D. and Reeve, Emily (2021). Alterations in drug disposition in older adults: a focus on geriatric syndromes. Expert Opinion on Drug Metabolism and Toxicology, 17 (1), 41-52. doi: 10.1080/17425255.2021.1839413
Medication use quality and safety in older adults: 2018 update
Ailabouni, Nagham J., Marcum, Zachary A., Schmader, Kenneth E. and Gray, Shelly L. (2019). Medication use quality and safety in older adults: 2018 update. Journal of the American Geriatrics Society, 67 (12), 2458-2462. doi: 10.1111/jgs.16243
Ailabouni, Nagham J. and Reeve, Emily (2019). Can existing tools predict older adults' willingness to deprescribe? Considerations for D-PRESCRIBE's post-hoc secondary analysis. Research in Social and Administrative Pharmacy, 15 (11), 1379-1380. doi: 10.1016/j.sapharm.2019.08.025
Ailabouni, Nagham, Mangin, Dee and Nishtala, Prasad S. (2019). DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities. International Journal of Clinical Pharmacy, 41 (1), 167-178. doi: 10.1007/s11096-019-00784-9
Ailabouni, Nagham, Mangin, Dee and Nishtala, Prasad S (2017). Deprescribing anticholinergic and sedative medicines: Protocol for a Feasibility Trial (DEFEAT-polypharmacy) in residential aged care facilities. BMJ Open, 7 (4) e013800. doi: 10.1136/bmjopen-2016-013800
Ailabouni, Nagham, Tordoff, June, Mangin, Dee and Nishtala, Prasad S. (2017). Do residents need all their medications? A cross-sectional survey of RNs' views on deprescribing and the role of clinical pharmacists. Journal of Gerontological Nursing, 43 (10), 13-20. doi: 10.3928/00989134-20170914-05
Tordoff, June M., Ailabouni, Nagham J., Browne, Dorothy P., Al-Sallami, Hesham S. and Gray, Andrew R. (2016). Improvements in the prescribing of antipsychotics in dementia and psychogeriatric units in New Zealand. International Journal of Clinical Pharmacy, 38 (4), 941-949. doi: 10.1007/s11096-016-0318-1
Challenges and enablers of deprescribing: a general practitioner perspective
Ailabouni, Nagham J., Nishtala, Prasad S., Mangin, Dee and Tordoff, June M. (2016). Challenges and enablers of deprescribing: a general practitioner perspective. PLoS One, 11 (4) 0151066. doi: 10.1371/journal.pone.0151066
Ailabouni, N. J., Nishtala, P. S., Mangin, D. and Tordoff, J. M. (2016). General practitioners' insight into deprescribing for the multimorbid older individual: a qualitative study. International Journal of Clinical Practice, 70 (3), 261-276. doi: 10.1111/ijcp.12780
Examining potentially inappropriate prescribing in residential care using the STOPP/START criteria
Ailabouni, N. J., Nishtala, P. S. and Tordoff, J. M. (2016). Examining potentially inappropriate prescribing in residential care using the STOPP/START criteria. European Geriatric Medicine, 7 (1), 40-46. doi: 10.1016/j.eurger.2015.11.004
Shafiee Hanjani, Leila, Weir, Kristie, Reeve, Emily, Brandt, Nicole, Tao, Eric and Ailabouni, Nagham J. (2023). Co-designing The Prime Tool To Empower People Living With Dementia And Their Carers To Initiate Deprescribing Conversations. FIP World Congress, Brisbane, QLD Australia, 24 - 28 September 2023.
Elsedfy, Youmna, Mangin, Dee, Jamieson, Hamish, Bergler, Ulrich, Nishtala, Prasad, Weaver, Susan K., Reeve, Emily, Freeman, Christopher R. and Ailabouni, Nagham (2023). An International Comparison Of Deprescribing Interventional Studies: How To Determine Factors That Contribute To Translational Deprescribing Success?. FIP World Congress, Brisbane, QLD Australia, 24 - 28 September 2023.
Ming, Jiun, Reeve, Emily, Chai, Wern Chern, Ailabouni, Nagham, Proudman, Susanna and Wiese, Michael (2023). Attitudes of healthcare professional towards the use of parenteral methotrexate in rheumatoid arthritis patients: a qualitative study. 2023 Australian Rheumatology Association (ARA) 63rd Annual Scientific Meeting, Hobart, TAS, Australia, 6–9 May 2023. Richmond, VIC, Australia: John Wiley & Sons. doi: 10.1111/imj.16057
Maher, Dorsa, Reeve, Emily, Hopkins, Ashley, Tan, Jiun Ming, Tantiongco, Mahsa, Ailabouni, Nagham, Woodman, Richard, Stamp, Lisa, Bursill, David, Proudman, Susanna and Wiese, Michael (2023). Preventing gout flares when introducing or escalating urate-lowering therapy: a systematic review and network meta-analysis. 2023 Australian Rheumatology Association (ARA) 63rd Annual Scientific Meeting, Hobart, TAS, Australia, 6–9 May 2023. Richmond, VIC, Australia: John Wiley & Sons. doi: 10.1111/imj.16057
Preventing urate-lowering therapy induced gout flares: a systematic review and network meta-analysis
Maher, Dorsa, Reeve, Emily, Tan, Jiun Ming, Tantiongco, Mahsa M., Ailabouni, Nagham J., Hopkins, Ashley M., Woodman, Richard J., Stamp, Lisa, Bursill, David, Proudman, Susanna and Wiese, Michael D. (2022). Preventing urate-lowering therapy induced gout flares: a systematic review and network meta-analysis. APSA-ASCEPT, Perth, WA, Australia, 29 November - 2 December 2022.
Co-designing deprescribing guidelines’ implementation into hospital for people living with dementia
Ailabouni, Nagham J., Weir, Kristie, Maher, Dorsa, Hilmer, Sarah, Koeper, Ivanka, Russell, Patrick, Shakib, Sepehr and Reeve, Emily (2022). Co-designing deprescribing guidelines’ implementation into hospital for people living with dementia. APSA-ASCEPT, Perth, WA Australia, 29 November - 2 December 2022.
Murray, Lauren, Reeve, Emily, Ailabouni, Nagham, Kalisch Ellett, Lisa and Weise, Michael (2022). Attitudes of Rheumatoid Arthritis (RA) patients towards Disease Modifying Anti-rheumatic drugs (DMARD) deprescribing. The Pharmaceutical Society of Australia, Sydney, Australia, 29-31 July 2022.
(2024–2028) NHMRC Investigator Grants
(2023–2027) NHMRC MRFF - Preventive and Public Health Research
Co-designing an evidence-based deprescribing training package for clinicians to optimise medication use and reduce risk of medication-related harm for people living with dementia
Doctor Philosophy — Principal Advisor
Other advisors:
Leveraging implementation science concepts to improve the translation of healthcare services that improve Quality Use of Medicines
Doctor Philosophy — Principal Advisor
Other advisors: